Chesterfield, MO, United States of America

Timothy S Chamberlain


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1992-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Timothy S. Chamberlain

Introduction

Timothy S. Chamberlain is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as angiotensin II antagonists for the control of hypertension. With a total of 2 patents to his name, his work has the potential to impact the treatment of high blood pressure.

Latest Patents

Chamberlain's latest patents focus on a class of cycloheptimidazolone compounds. These compounds are described as angiotensin II antagonists, which are crucial for managing hypertension. The compounds of particular interest are characterized by specific chemical formulas, where various substituents can be selected from a range of functional groups. This innovative approach aims to provide effective pharmaceutical solutions for patients suffering from hypertension.

Career Highlights

Timothy S. Chamberlain has been associated with G.D. Searle & Company, where he has contributed to groundbreaking research and development in the pharmaceutical industry. His expertise in medicinal chemistry and drug design has positioned him as a valuable asset in the field.

Collaborations

Chamberlain has worked alongside esteemed colleagues such as Philippe R. Bovy and Joan M. O'Neal. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical compounds.

Conclusion

Timothy S. Chamberlain's contributions to the field of pharmaceuticals, particularly through his patents on cycloheptimidazolone compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in hypertension treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…